Medium materiality6/10
H.C. Wainwright Reiterates Buy Rating on Candel Therapeutics Inc. (CADL)
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright reiterates Buy on CADL; target $23; current price $9.68.
- Wainwright reiterates Buy; target $23; price $9.68.
Key facts
- 01
Target: $23
- 02
Posted price: $9.68
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Andres Maldonado
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.